Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Lancet (London, England)|January 18, 2006
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trialStefan Janssens, Christophe Dubois, Jan Bogaert, et al.
Acta Neurologica Belgica|March 15, 2018
A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosisGuy Laureys, Barbara Willekens, Ludo Vanopdenbosch, et al.
Hematology (Amsterdam, Netherlands)|August 14, 2025
Real-world outcomes in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia treated with ponatinib - final 6-year results from a Belgian registryTimothy Devos, Dries Deeren, Koen Theunissen, et al.
Bone Marrow Transplantation|January 31, 2019
Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centresHélène A Poirel, Marijke Vanspauwen, Gilles Macq, et al.
Blood|May 25, 2006
Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow TransplantationRodrigo Martino, Rocio Parody, Takahiro Fukuda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 18, 2013
Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow TransplantationJan Styczynski, Lidia Gil, Gloria Tridello, et al.
Leukemia Research|March 26, 2014
Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromesMichel Delforge, Dominik Selleslag, Yves Beguin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT)Desmond Curran, Sean Matthews, Scott D Rowley, et al.
Hemasphere|August 5, 2021
Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 TrialHartmut Döhner, Argiris Symeonidis, Dries Deeren, et al.
The New England Journal of Medicine|December 9, 2024
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple MyelomaMeletios A Dimopoulos, Peter M Voorhees, Fredrik Schjesvold, et al.
Pageof 4